Literature DB >> 17370429

Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network.

S Li1, Z Q Zhang, L J Wu, X G Zhang, Y D Li, Y Y Wang.   

Abstract

Traditional Chinese medicine uses ZHENG as the key pathological principle to understand the human homeostasis and guide the applications of Chinese herbs. Here, a systems biology approach with the combination of computational analysis and animal experiment is used to investigate this complex issue, ZHENG, in the context of the neuro-endocrine-immune (NEI) system. By using the methods of literature mining, network analysis and topological comparison, it is found that hormones are predominant in the Cold ZHENG network, immune factors are predominant in the Hot ZHENG network, and these two networks are connected by neuro-transmitters. In addition, genes related to Hot ZHENG-related diseases are mainly present in the cytokine-cytokine receptor interaction pathway, whereas genes related to both the Cold-related and Hot-related diseases are linked to the neuroactive ligand-receptor interaction pathway. These computational findings were subsequently verified by experiments on a rat model of collagen-induced arthritis, which indicate that the Cold ZHENG-oriented herbs tend to affect the hub nodes in the Cold ZHENG network, and the Hot ZHENG-oriented herbs tend to affect the hub nodes in the Hot ZHENG network. These investigations demonstrate that the thousand-year-old concept of ZHENG may have a molecular basis with NEI as background.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17370429     DOI: 10.1049/iet-syb:20060032

Source DB:  PubMed          Journal:  IET Syst Biol        ISSN: 1751-8849            Impact factor:   1.615


  146 in total

1.  Perspective: All systems go.

Authors:  Jan van der Greef
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

Review 2.  Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials.

Authors:  Chun Ho Ma; Wai Ling Lin; Sing Leung Lui; Xun-Yuan Cai; Vivian Taam Wong; Eric Ziea; Zhang-Jin Zhang
Journal:  Asian J Androl       Date:  2013-06-03       Impact factor: 3.285

Review 3.  Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches.

Authors:  Jie Wang; Gui Yu
Journal:  Chin J Integr Med       Date:  2013-08-05       Impact factor: 1.978

4.  Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.

Authors:  Yan-qiong Zhang; Song-song Wang; Wei-liang Zhu; Yan Ma; Fang-bo Zhang; Ri-xin Liang; Hai-Yu Xu; Hong-jun Yang
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

5.  Standardization and future directions in pattern identification research: International brainstorming session.

Authors:  Jeeyoun Jung; Bongki Park; Ju Ah Lee; Sooseong You; Terje Alraek; Zhao-Xiang Bian; Stephen Birch; Tae-Hun Kim; Hao Xu; Chris Zaslawski; Byoung-Kab Kang; Myeong Soo Lee
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

6.  Bridging the traditional Chinese medicine pattern classification and biomedical disease diagnosis with systems biology.

Authors:  Ai-ping Lu; Zhao-xiang Bian; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

7.  Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.

Authors:  Yan-Qiong Zhang; Qiu-Yan Guo; Qiu-Yue Li; Wei-Qiong Ren; Shi-Huan Tang; Song-Song Wang; Ri-Xin Liang; De-Feng Li; Yi Zhang; Hai-Yu Xu; Hong-Jun Yang
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

8.  Effect of serum from postmenopausal women with osteoporosis exhibiting the Kidney-Yang deficiency pattern on bone formation in an hFOB 1.19 human osteoblastic cell line.

Authors:  Yachan Li; Wenna Liang; Xihai Li; Bizhen Gao; Huijuan Gan; Lianhua Yin; Jianying Shen; Jie Kang; Shanshan Ding; Xuejuan Lin; Linghong Liao; Candong Li
Journal:  Exp Ther Med       Date:  2015-07-03       Impact factor: 2.447

9.  Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms of Li-Ru-Kang against hyperplasia of mammary gland.

Authors:  Shizhang Wei; Xuelin Zhou; Ming Niu; Haizhu Zhang; Xiaoyi Liu; Ruilin Wang; Pengyan Li; Haotian Li; Huadan Cai; Yanling Zhao
Journal:  Mol Genet Genomics       Date:  2019-05-03       Impact factor: 3.291

10.  Yin-yang and Zheng: Exported from Chinese medicine.

Authors:  Hong-ji Zhang; Zhan-xiang Wang
Journal:  Chin J Integr Med       Date:  2014-04-03       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.